Puberty blockers will no longer be prescribed to minors under age 18 in England outside of regulated clinical trials, the country’s National Health Service announced Tuesday, following an earlier review by the agency, the latest development in the controversial treatment that has sparked protests in the U.S., as well, over gender-affirming care in children.

<div class="image-embed__placeholder"><img src="https://specials-images.forbesimg.com/imageserve/65f0a4e5cd05ca0c22e5e3d1/NHS/960x0.jpg?cropX1=0&amp;cropX2=1642&amp;cropY1=134&amp;cropY2=1057" alt="NHS" width="100%" height="auto"></div><figcaption><fbs-accordion class="expandable" current="-1"><p class="color-body light-text">An earlier review by England’s National Health Service found a “lack of consensus and open dialogue” <span class="plus" data-ga-track="caption expand">... [+]</span><span class="expanded-caption"> about gender dysphoria.</span></p></fbs-accordion><small>Getty Images</small></figcaption>

 <div class="key-facts-element"> <p><em>This is a developing story and will be updated.</em></p>  </div>


An earlier review by England’s National Health Service found a “lack of consensus and open dialogue” about gender dysphoria.{ai:summary}<p>Puberty blockers banned for minors under 18 in England amid controversy over gender-affirming care. #health</p>

UK Bans Puberty Blockers For Minors

Loading...